Targeting gut microbiota: new therapeutic opportunities in multiple sclerosis-Reference-Cited by-同舟云学术

Targeting gut microbiota: new therapeutic opportunities in multiple sclerosis

Published:2023-11-18 Issue:2 Volume:15 Page:
ISSN:1949-0976
Container-title:Gut Microbes
language:en
Short-container-title:Gut Microbes

Author:

Kujawa Dorota¹,Laczmanski Lukasz¹,Budrewicz Slawomir²,Pokryszko-Dragan Anna²,Podbielska Maria³^ORCID

Affiliation:

1. Laboratory of Genomics & Bioinformatics, Ludwik Hirszfeld Institute of Immunology & Experimental Therapy, Polish Academy of Sciences, Wroclaw, Poland

2. Department of Neurology, Wroclaw Medical University, Wroclaw, Poland

3. Laboratory of Microbiome Immunobiology, Ludwik Hirszfeld Institute of Immunology & Experimental Therapy, Polish Academy of Sciences, Wroclaw, Poland

Funder

Uniwersytet Medyczny im. Piastów Slaskich we Wroclawiu

Publisher

Informa UK Limited

Subject

Infectious Diseases,Microbiology (medical),Gastroenterology,Microbiology

Link

https://www.tandfonline.com/doi/pdf/10.1080/19490976.2023.2274126

Reference207 articles.

1. Multiple sclerosis

2. Environmental and genetic risk factors for MS: an integrated review

3. The role of infections in multiple sclerosis

4. The Interaction between Viral and Environmental Risk Factors in the Pathogenesis of Multiple Sclerosis

5. Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relationship between gut microbiota and multiple sclerosis: a scientometric visual analysis from 2010 to 2023;Frontiers in Immunology;2024-08-19

2. Causal effects of gut microbiota on multiple sclerosis: A two‐sample Mendelian randomization study;Brain and Behavior;2024-06

3. The Immunomodulatory Potential of Short-Chain Fatty Acids in Multiple Sclerosis;International Journal of Molecular Sciences;2024-03-11

4. Multiple sclerosis and lifestyle;British Journal of Neuroscience Nursing;2024-02-01